Growth Metrics

Mannkind (MNKD) Interest Coverage Ratio Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 15.31%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -76.51%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -303.06%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 18.06%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.72%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,150.63%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -104.64%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -104.64%
Dec 31, 2025 -106.01%
Sep 30, 2025 95.53%
Jun 30, 2025 577.34%
Mar 31, 2025 -26.32%
Dec 31, 2024 477.86%
Sep 30, 2024 291.29%
Jun 30, 2024 996.25%
Mar 31, 2024 402.58%
Dec 31, 2023 164.47%
Sep 30, 2023 152.98%
Jun 30, 2023 108.13%
Mar 31, 2023 72.17%
Dec 31, 2022 47.40%
Sep 30, 2022 -45.36%
Jun 30, 2022 4.67%
Mar 31, 2022 -706.12%
Dec 31, 2021 -128.14%
Sep 30, 2021 72.78%
Jun 30, 2021 55.76%
Mar 31, 2021 85.57%
Dec 31, 2020 65.88%
Sep 30, 2020 -305.96%
Jun 30, 2020 62.40%
Mar 31, 2020 70.82%
Dec 31, 2019 10.82%
Sep 30, 2019 90.19%
Jun 30, 2019 -61.59%
Mar 31, 2019 -52.61%
Dec 31, 2018 11.11%
Sep 30, 2018 -77.85%
Jun 30, 2018 7.81%
Mar 31, 2018 -106.14%
Dec 31, 2017 -256.66%
Sep 30, 2017 -142.98%
Jun 30, 2017 -184.98%
Mar 31, 2017 -52.78%
Dec 31, 2016 95.20%
Sep 30, 2016 552.38%
Jun 30, 2016 21.44%
Mar 31, 2016 -26.50%
Dec 31, 2015 -1,438.10%
Sep 30, 2015 11.08%
Jun 30, 2015 79.75%
Mar 31, 2015 63.42%
Dec 31, 2014 -30.75%
Sep 30, 2014 31.87%
Jun 30, 2014 -98.18%
Mar 31, 2014 19.50%
Dec 31, 2013 -62.00%
Sep 30, 2013 16.58%
Jun 30, 2013 6.33%
Mar 31, 2013 3.42%
Dec 31, 2012 76.58%
Sep 30, 2012 -7.75%
Jun 30, 2012 -12.03%
Mar 31, 2012 16.32%
Dec 31, 2011 5.32%
Sep 30, 2011 49.20%
Jun 30, 2011 55.06%